Phosphodiesterase (PDE) Inhibitors Market to Witness Robust Expansion by 2029
Phosphodiesterase (PDE) inhibitors market is anticipated
to grow at a significant CAGR during the forecast period. The PDE is found in
the cytosol, plasma membranes, endoplasmic reticulum, nuclear membranes, and
cytoskeleton. Majorly, the two types of PDE inhibitors including the selective
and non-selective are being discovered as possible treatments for various
indications, such as chronic obstructive pulmonary disease (COPD), Alzheimer’s
disease, and other ailments. Thus, such novel application of these inhibitors
in the treatment of various diseases is promising a strong market growth during
the forecast period. Another pivotal factor that is driving the global PDE
inhibitors market growth includes the rise in the prevalence of erectile
dysfunction disorder. According to the World Health Organization, about 150
million people have been affected by erectile dysfunction across the globe and
the number is projected to reach 230 million by 2025. It is a common medical
condition affecting about 15% of men each year.
Some key players operating in the market include
Bayer AG, Eli Lilly and Co., GlaxoSmithKline Plc, and Pfizer Inc., among
others. These players are eyeing to strengthen their position in the market by
adopting various strategies as mergers and acquisitions, partnerships,
collaborations, new product launch and development in the existing product
portfolio, and so on. For instance, in July 2018, Adamis Pharmaceuticals Corp.
(Adamis) announced that it has been conducting pre-IND development work for a
fast-dissolving sublingual tablet containing tadalafil, which is a drug used to
treat erectile dysfunction. Further, in September 2020, Aspargo Laboratories,
Inc. acquired the international rights to Sildenafil oral spray for the
treatment of erectile dysfunction.
To Request a Sample of our Report on
Phosphodiesterase (PDE) Inhibitors Market: https://www.omrglobal.com/request-sample/phosphodiesterase-pde-inhibitors-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2023-2030
·
Segment Covered
·
Regions Covered- Globally
Competitive Landscape: Bayer AG, Eli Lilly and Co., GlaxoSmithKline Plc,
and Pfizer Inc., among others.
A
full Report of Phosphodiesterase (PDE) Inhibitors Market is Available @ https://www.omrglobal.com/industry-reports/phosphodiesterase-pde-inhibitors-market
Phosphodiesterase (PDE) Inhibitors Market by
Segmentation
By Type
•
Selective PDE Inhibitors
·
PDE-1
·
PDE-2
·
PDE-3
·
PDE-4
·
PDE-5
·
Others
•
Non-Selective PDE Inhibitors
By Route of
Administration
•
Oral
•
Topical
•
Others
By Application
•
CVD
•
Erectile Dysfunction
•
Pulmonary Hypertension
•
Respiratory Disease
•
Benign Prostate Hyperplasia
•
Others
Phosphodiesterase (PDE)
Inhibitors Market by Region
Regional Analysis
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/phosphodiesterase-pde-inhibitors-market
About Orion Market Research
Orion Market Research (OMR) is a market research
and consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing
services through its subsidiary OMR Digital and Software development and
Consulting Services through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment